SE5129C1 - - Google Patents

Info

Publication number
SE5129C1
SE5129C1 SE5129DA SE5129C1 SE 5129 C1 SE5129 C1 SE 5129C1 SE 5129D A SE5129D A SE 5129DA SE 5129 C1 SE5129 C1 SE 5129C1
Authority
SE
Sweden
Application number
Publication date
Publication of SE5129C1 publication Critical patent/SE5129C1/xx

Links

SE5129D SE5129C1 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE5129T

Publications (1)

Publication Number Publication Date
SE5129C1 true SE5129C1 (sv) 1894-05-19

Family

ID=41826529

Family Applications (1)

Application Number Title Priority Date Filing Date
SE5129D SE5129C1 (sv)

Country Status (1)

Country Link
SE (1) SE5129C1 (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435406A (en) 1980-08-21 1984-03-06 Hoffmann-La Roche Inc. Imidazole derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435406A (en) 1980-08-21 1984-03-06 Hoffmann-La Roche Inc. Imidazole derivatives

Similar Documents

Publication Publication Date Title
GB189416303A (sv)
AT2000B (sv)
FR235586A (sv)
AT153B (sv)
AT895B (sv)
GB189410690A (sv)
AT1972B (sv)
AT5048B (sv)
AT281B (sv)
AT1980B (sv)
AT1127B (sv)
AT2042B (sv)
AT2159B (sv)
AT2561B (sv)
AT344B (sv)
AT13547B (sv)
AT1125B (sv)
AT1470B (sv)
AT150B (sv)
GB189419582A (sv)
GB189409904A (sv)
AT301B (sv)
AT1467B (sv)
AT865B (sv)
AT287B (sv)